How have MRMD shares performed in 2024?

MariMed's stock was trading at $0.2748 at the start of the year. Since then, MRMD shares have increased by 0.6% and is now trading at $0.2765. View the best growth stocks for 2024 here .

Are investors shorting MariMed?

MariMed saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 34,400 shares, a decline of 35.3% from the March 15th total of 53,200 shares. Based on an average daily trading volume, of 1,116,200 shares, the short-interest ratio is presently 0.0 days. View MariMed's Short Interest .

How were MariMed's earnings last quarter?

MariMed Inc. (OTCMKTS:MRMD) issued its quarterly earnings data on Monday, November, 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $33.21 million for the quarter. MariMed had a negative net margin of 10.79% and a negative trailing twelve-month return on equity of 1.84%.

What guidance has MariMed issued on next quarter's earnings?

MariMed issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $156.0 million-$159.0 million, compared to the consensus revenue estimate of $173.8 million.

What other stocks do shareholders of MariMed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MariMed investors own include KushCo (KSHB) , Organigram (OGI) , Auxly Cannabis Group (CBWTF) , CNBX Pharmaceuticals (CNBX) , Supreme Cannabis (SPRWF) , Gran Tierra Energy (GTE) , Pennsylvania Real Estate Investment Trust (PEI) , GB Sciences (GBLX) , Medical Marijuana (MJNA) and Smart Cannabis (SCNA) .

How do I buy shares of MariMed?

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:MRMD

MariMed (MRMD) Stock Price, News & Analysis

→ Chances are you know the firms on this list (From WealthPress) (Ad)

Free MRMD Stock Alerts

$0.28

+0.01 (+3.75%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.26
▼
$0.28
50-Day Range: $0.20
▼
$0.33
52-Week Range: $0.20
▼
$0.55

Volume: 162,144 shs
Average Volume: 481,254 shs
Market Capitalization: $103.72 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials Headlines SEC Filings Short Interest

Get MariMed alerts:

Ad Priority Gold

Biden to Launch “FedNOW” [Move Your Money Now]

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

Get your free information kit NOW, before it's too late.

About MariMed Stock (OTCMKTS:MRMD)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

MRMD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MRMD Stock News Headlines

April 17, 2024 | benzinga.com

'A F—ed-Up Situation,' Says MariMed CCO About How State Regulations Complicate Cannabis Edibles Strategy

April 16, 2024 | americanbankingnews.com

Critical Review: MariMed (OTCMKTS:MRMD) versus Cronos Group (NASDAQ:CRON)

April 18, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

April 13, 2024 | uk.investing.com

MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois Dispensary

April 11, 2024 | msn.com

MariMed Is On A Roll: Partners With Two Iconic Music Venues In Boston, Acquires Another Illinois Cannabis Dispensary

April 11, 2024 | finance.yahoo.com

MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary

April 11, 2024 | finance.yahoo.com

MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary

April 11, 2024 | globenewswire.com

MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois Dispensary

April 18, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

April 10, 2024 | bizjournals.com

Mass. cannabis firm sponsors MGM Music Hall, House of Blues

April 10, 2024 | globenewswire.com

MariMed Partners with Iconic Boston Music Venues

April 10, 2024 | globenewswire.com

MariMed Partners with Iconic Boston Music Venues

April 9, 2024 | finanznachrichten.de

MariMed Inc.: MariMed Closes Acquisition of Second Maryland Dispensary

April 9, 2024 | globenewswire.com

MariMed Closes Acquisition of Second Maryland Dispensary

April 8, 2024 | globenewswire.com

MariMed Announces First Quarter 2024 Earnings Date

March 27, 2024 | msn.com

'Unsexy' Alternative, Operating Within Constraints, Consistency & Love: 3 Experts On Making Cannabis Businesses Self-Sustainable

March 12, 2024 | globenewswire.com

A Bigger Dispensary Opens in the Town of “Big Things” as MariMed Opens Larger, Permanent Thrive Dispensary in Casey, Illinois

March 9, 2024 | seekingalpha.com

MariMed Inc. (MRMD) Q4 2023 Earnings Call Transcript

March 8, 2024 | finance.yahoo.com

MariMed Inc. (PNK:MRMD) Q4 2023 Earnings Call Transcript

March 8, 2024 | finanznachrichten.de

MariMed Inc.: MariMed Reports Fourth Quarter and Full Year 2023 Earnings

March 7, 2024 | msn.com

MariMed Reports 'Another Year Of Strong Operational And Financial Performance' And More To Come In 2024

March 7, 2024 | investorplace.com

MRMD Stock Earnings: MariMed Beats Revenue for Q4 2023

March 6, 2024 | benzinga.com

MariMed's Earnings: A Preview

March 6, 2024 | globenewswire.com

MariMed Reports Fourth Quarter and Full Year 2023 Earnings

March 4, 2024 | finance.yahoo.com

MariMed’s Betty’s Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night’s Sleep

March 4, 2024 | globenewswire.com

MariMed's Betty's Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night's Sleep

March 4, 2024 | globenewswire.com

MariMed's Betty's Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night's Sleep

See More Headlines

Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/15/2021
Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medicinals & botanicals
Sub-Industry: N/A
Current Symbol: OTCMKTS:MRMD
CUSIP: N/A
CIK: 1522767
Web: marimedadvisors.com
Phone: (617) 795-5140
Fax: N/A
Employees: 643
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.04)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-16,030,000.00
Net Margins: -10.79%
Pretax Margin: -4.44%
Return on Equity: -1.84%
Return on Assets: -0.72%

Debt

Debt-to-Equity Ratio: 0.97
Current Ratio: 1.67
Quick Ratio: 0.85

Sales & Book Value

Annual Sales: $148.60 million
Price / Sales: 0.68
Cash Flow: $0.03 per share
Price / Cash Flow: 9.43
Book Value: $0.19 per share
Price / Book: 1.41

Miscellaneous

Outstanding Shares: 375,130,000
Free Float: 298,041,000
Market Cap: $100.78 million
Optionable: Not Optionable
Beta: 2.85

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Jon R. Levine (Age 59)
Co-Founder, CEO, Interim CFO, President, Secretary, Treasurer & Director
Comp: $481.74k
Mr. Timothy Shaw (Age 46)
Chief Operating Officer
Comp: $445.86k
Mr. Jonathan W. Rider (Age 59)
Chief Information Officer
Mr. Steve Wayne West
Vice President of Investor Relations
Mr. Howard Schacter
Chief Communications Officer
Ms. Sara Gullickson (Age 39)
Vice President of Marketing
Mr. Ryan Crandall
Chief Revenue Officer
Mr. Charles Holt Finnie
Chief Strategy Officer

Key Competitors

View All Competitors

MRMD Stock Analysis - Frequently Asked Questions

How have MRMD shares performed in 2024?: MariMed's stock was trading at $0.2748 at the start of the year. Since then, MRMD shares have increased by 0.6% and is now trading at $0.2765.
View the best growth stocks for 2024 here.
Are investors shorting MariMed?: MariMed saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 34,400 shares, a decline of 35.3% from the March 15th total of 53,200 shares. Based on an average daily trading volume, of 1,116,200 shares, the short-interest ratio is presently 0.0 days.
View MariMed's Short Interest.
How were MariMed's earnings last quarter?: MariMed Inc. (OTCMKTS:MRMD) issued its quarterly earnings data on Monday, November, 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm had revenue of $33.21 million for the quarter. MariMed had a negative net margin of 10.79% and a negative trailing twelve-month return on equity of 1.84%.
What guidance has MariMed issued on next quarter's earnings?: MariMed issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $156.0 million-$159.0 million, compared to the consensus revenue estimate of $173.8 million.

What other stocks do shareholders of MariMed own?: Based on aggregate information from My MarketBeat watchlists, some companies that other MariMed investors own include KushCo (KSHB), Organigram (OGI), Auxly Cannabis Group (CBWTF), CNBX Pharmaceuticals (CNBX), Supreme Cannabis (SPRWF), Gran Tierra Energy (GTE), Pennsylvania Real Estate Investment Trust (PEI), GB Sciences (GBLX), Medical Marijuana (MJNA) and Smart Cannabis (SCNA).
How do I buy shares of MariMed?: Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MRMD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial